secondary hyperthyroidism

sec·on·dar·y hy·per·thy·roid·ism

hyperthyroidism due to stimulation of the thyroid gland by an excess of thyrotrophin secreted by the pituitary gland.
References in periodicals archive ?
Its mainstay drug, Epogin, a recombinant human granulocyte-colony stimulating factor, particularly contributed to the sales growth while new drugs Suvenyl, used to improve joint function, and Oxarol, a treatment for secondary hyperthyroidism, also sold well.
Certain cats may develop goiter while retaining normal thyroid function, suggesting that the thyroid gland may enlarge first, leading to secondary hyperthyroidism.
Meanwhile, REGPARA Tablets, a treatment for secondary hyperthyroidism during dialysis therapy, are achieving steady market penetration.
However, in the Pharmaceuticals segment we expect performance to be below our initial expectations due to lower than expected sales of anemia treatments NESP and ESPO, and REGPARA, a treatment for secondary hyperthyroidism during dialysis therapy.
At Kirin Pharma, in a severe competitive environment for core anemia products ESPO and NESP we are actively providing information on our products to medical practitioners, while efforts are being made to achieve rapid market penetration of REGPARA Tablets, a treatment for secondary hyperthyroidism during dialysis therapy that was launched in January 2008.
Full browser ?